EKIP– Expert Club for Economics and Politics A Different Opinion
|Full text of the analysis| The results of the study of the Bulgarian market show the conclusions of previous analyses, such as the one commissioned by the European Commission in 2019, concerning the positive effects of the entry of biosimilar medicines into European markets. In other words, price competition between biosimilar medicines and reference medicines (together and among themselves) allows …
More »Reform to improve access to healthcare in Bulgaria
